Latest News and Press Releases

eureKARE to host SynBio Day 2022 entitled‘Synthetic Biology for the Protection of our Planet’ To be held 13-14 October in person in Monaco and online; delegates can access the virtual event...

eureKARE launches synthetic biology studio network with inaugural biomedical studio in Belgium Georges Rawadi appointed eureKARE’s Chief of Biotech Studio Development Luxembourg, Belgium, and...

eureKARE supports eureKING in EUR 150 million listing of the first European healthcare SPAC dedicated to biomanufacturing Launch of eureKING represents a milestone in eureKARE’s mission to harness...

eureKARE Joins DNA Data Storage Alliance eureKARE joins the DNA Data Storage Alliance founded by Illumina, Inc., Microsoft, Twist Bioscience Corporation and Western Digital Members collaborate to...

eureKARE participates in DNA Script’s $200 Million Series C Financing Fundraise will accelerate commercial launch of revolutionary enzymatic DNA printing technology Luxembourg and Paris, France –...

eureKARE successfully hosts inaugural SynBio Day and EureKAWARDS Congratulations to the first eureKAWARDS pitch contest winner, Prof. Roy Bar-Ziv of the Weizmann Institute of ScienceThank you to...

eureKARE announces participation of the European Innovation Council in the opening of the eureKAWARDS Dr Iordanis Arzimanoglou, European Innovation Council Programme Manager for Health and...

Potter Clarkson and ERS Genomics to join forces with eureKARE on the eureKAWARDS Potter Clarkson to offer the winner a Kick-StartiP consultancy ERS Genomics to provide the most promising...

eureKARE launches inaugural eureKAWARDS to support European synthetic biology innovation Opportunity to showcase ground-breaking ideas, concepts, and business plans in front of Europe’s leading...

eureKARE invests in Coave Therapeutics as part of its €33 million Series B roundFourth portfolio investment in clinical stage ocular and CNS focused gene therapy company Luxembourg and Paris,...